UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians specializing in radiation therapies will present latest research at ASTRO meeting, showcasing 23 abstracts on key areas such as survivorship, lung cancer, sarcoma, and more. Noteworthy studies include a genetic signature predicting response to chemoradiotherapy in rectal cancer, MRI-guided SBRT showing fewer side effects than CT-guided treatment for prostate cancer, and a study on using mPROS app for symptom monitoring during radiation therapy. These studies aim to improve patient outcomes and personalize treatment approaches. Presented findings have potential to shape future of cancer treatment.
Source link
UCLA Health researchers showcase advances in radiation oncology at ASTRO
